Literature DB >> 6130956

Inotropic beta-blocking potency (pA2) and partial agonist activity of propranolol, practolol, sotalol and acebutolol.

M J Lewis, A C Grey, A H Henderson.   

Abstract

The beta-blocking potencies (pA2 values) and cumulative dose responses of the direct effects of dl-propranolol, practolol, acebutolol and sotalol have been characterised in respect of the mechanical performance of isolated cat papillary muscle preparations. pA2 values calculated from antagonism of each of the drugs to the inotropic effect of isoprenaline at 29 degrees C were: dl-propranolol 8.3, practolol 5.6, acebutolol 7.5 and sotalol 4.8. The responses in reserpinized muscles were similar to those in non-reserpinized preparations. dl-Propranolol at concentrations of 10(-5) and 10(-4) M depressed peak developed force (DF) and rate of force development (+dF/dt) by 20% and 60% respectively, with similar but smaller changes in maximum unloaded shortening velocity ('Vmax'). Practolol and sotalol increased DF and +dF/dt by less than 10% at 10(-5) M and by 10-20% at 10(-4) M, with similar but smaller changes in Vmax. Sotalol induced prolonged biphasic contractions at 10(-4) M. Acebutolol had no effect on DF, +dF/dt, or Vmax. Time to peak force and half isometric relaxation time were not altered by any drug. Practolol and acebutolol, generally considered to have partial agonist activity, exerted this to a negligible degree in respect of inotropic effect at less than or equal to 10(-5) M.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6130956     DOI: 10.1016/0014-2999(82)90398-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

Review 1.  Sotalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

Authors:  B N Singh; P Deedwania; K Nademanee; A Ward; E M Sorkin
Journal:  Drugs       Date:  1987-09       Impact factor: 9.546

2.  Sotalol versus class I and II antiarrhythmic agents.

Authors:  J J Hanyok; D J MacNeil
Journal:  Cardiovasc Drugs Ther       Date:  1990-06       Impact factor: 3.727

Review 3.  Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.

Authors:  A Fitton; E M Sorkin
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

4.  A study on the ocular and extraocular pharmacology of metipranolol.

Authors:  M F Sugrue; J M Armstrong; P Gautheron; P Mallorga; M P Viader
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1985       Impact factor: 3.117

5.  β-arrestin2 recruitment at the β2 adrenergic receptor: A luciferase complementation assay adapted for undergraduate training in pharmacology.

Authors:  Mattia Ferraiolo; Pauline Beckers; Nicolas Marquet; Martin Roumain; Lucie Ruiz; Nadine Dupuis; Julien Hanson; Emmanuel Hermans
Journal:  Pharmacol Res Perspect       Date:  2021-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.